Anne‐Louise Latif

A national service for delivering <scp>CD19 CAR‐T</scp>in large B‐cell lymphoma – The <scp>UK</scp> real‐world experience

Andrea Kühnl, Claire Roddie, Amy A. Kirkwood et al. · British Journal of Haematology · 2022 · 112 citations

Medicine, Hematology, Oncology +14

BRD4-mediated repression of p53 is a target for combination therapy in AML

Anne‐Louise Latif, Ashley Newcombe, Sha Li et al. · Nature Communications · 2021 · 78 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Molecular MRD is strongly prognostic in patients with <i>NPM1</i>-mutated AML receiving venetoclax-based nonintensive therapy

Jad Othman, Ing Soo Tiong, Jenny O’Nions et al. · Blood · 2023 · 65 citations · Full text

Medicine, Hematology, Oncology +14

FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML

Jad Othman, Nicola Potter, Katya Mokretar et al. · Leukemia · 2023 · 48 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy

Gloria Iacoboni, Josu Iraola‐Truchuelo, Maeve O’Reilly et al. · HemaSphere · 2024 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17